Porphyrias

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-04-03
Clinical Trial Update: Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria [Phase 2]
Phase 2 controlled trial of Panhematin for acute attacks of porphyria has completed and results have been posted.